238 related articles for article (PubMed ID: 67895)
1. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
[TBL] [Abstract][Full Text] [Related]
2. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
[TBL] [Abstract][Full Text] [Related]
3. Nitrosourea combinations in lung cancer.
Livingston RB
Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
McMahon LJ; Jones SE; Durie BG; Salmon SE
Cancer Lett; 1975 Nov; 1(2):97-102. PubMed ID: 65213
[TBL] [Abstract][Full Text] [Related]
5. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
[TBL] [Abstract][Full Text] [Related]
6. Treatment of small cell carcinoma of the lung using methyl-CCNU (NSC-95441) combined with cyclophosphamide (NSC-26271) and vincristine (NSC-67574) in a 3-week schedule.
Taylor SG; Donavan MA; Sponzo RW; Cunningham TJ; Horton J
Cancer Chemother Rep; 1975; 59(6):1127-30. PubMed ID: 769951
[TBL] [Abstract][Full Text] [Related]
7. New agents and combinations in the treatment of bronchogenic carcinoma.
Bodey GP; Gottlieb JA; Livingston R; Frei E
Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
[No Abstract] [Full Text] [Related]
8. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
Takita H; Brugarolas A; Mittelman A; Vincent R
Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
[No Abstract] [Full Text] [Related]
9. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
De Wasch G; Bernheim J; Michel J; Lejeune F; Kenis Y
Cancer Treat Rep; 1976 Sep; 60(9):1273-6. PubMed ID: 65222
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
[TBL] [Abstract][Full Text] [Related]
11. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
[TBL] [Abstract][Full Text] [Related]
12. A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Lenz C
Am J Clin Oncol; 1992 Dec; 15(6):480-6. PubMed ID: 1449109
[TBL] [Abstract][Full Text] [Related]
13. Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
Valdivieso M; Bodey GP; Benjamin RS; Barkley HT; Freeman MB; Ertel M; Smith TL; Mountain CF
Cancer Treat Rep; 1981; 65 Suppl 5():145-50. PubMed ID: 6809324
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
Livingston RB
Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
[No Abstract] [Full Text] [Related]
15. Therapy of advanced squamous carcinoma of the lung: cyclophosphamide vesus "COMB".
Bodey GP; Lagakos SW; Gutierrez AC; Wilson HE; Selawry OS
Cancer; 1977 Mar; 39(3):1026-31. PubMed ID: 71943
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
Whitehead RP; Rosenbaum PR; Carbone PP
Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
[TBL] [Abstract][Full Text] [Related]
17. The role of chemotherapy in the treatment of lung cancer.
Selawry OS
Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
[No Abstract] [Full Text] [Related]
18. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
[TBL] [Abstract][Full Text] [Related]
19. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
[TBL] [Abstract][Full Text] [Related]
20. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
Posey LE; Morgan LR
Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
